Biochemical Engineering

WuXi Vaccines to invest $392M for first foreign manufacturing site

WuXi Vaccines to invest $392M for first foreign manufacturing site

25th October 2019

WuXi Vaccines last week won approval to build a 15,520-square-meter, three-story vaccine manufacturing facility next to where it is building its biologics facility in Dundalk, Ireland, according to documents first reported by BioProcess International. Source: Fierce Pharma 25/10/2019


Back to group news